58% of ICU Patients Show Zinc Deficiency - Dr Zinx - Hinokitiol Increases Zinc Uptake
Retrieved on:
Tuesday, September 1, 2020
This study may show it necessary for patients coming into the ICU to be treated for Zinc deficiency and action taken to restore the number of zinc transporters.
Key Points:
- This study may show it necessary for patients coming into the ICU to be treated for Zinc deficiency and action taken to restore the number of zinc transporters.
- Zinc deficiency negatively impacts the growth and function of B and T cells, central effectors of the adaptive immune system.
- The potent synergistic interaction of Zinc and Hinokitiol has been demonstrated to inhibit the replication of RNA viruses in vitro.
- Hinokitiol acts as a Zinc ionophore, rapidly increasing the import of extracellular Zinc into cells, thus inhibiting viral replication.